Polaris Capital Management, LLC Jazz Pharmaceuticals PLC Transaction History

Polaris Capital Management, LLC

$1.34 Billion
Q2 2025

A detailed history of Polaris Capital Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Polaris Capital Management, LLC holds 634,160 shares of JAZZ stock, worth $71.9 Million. This represents 5.02% of its overall portfolio holdings.

Number of Shares

634,160

Previous 879,160 27.87%

Holding current value

$71.9 Million

Previous $109 Million 38.34%

% of portfolio

5.02%

Previous 7.17%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	SELL	$97.78 - $126.44 $24 Million - $31 Million	-245,000 Reduced 27.87%	634,160 $67.3 Million
Q1 2025 May 14, 2025	SELL	$120.07 - $144.17 $24.8 Million - $29.8 Million	-206,700 Reduced 19.04%	879,160 $109 Million
Q4 2024 Jan 29, 2025	SELL	$107.32 - $127.74 $23.6 Million - $28.1 Million	-219,700 Reduced 16.83%	1,085,860 $134 Million
Q3 2024 Nov 13, 2024	SELL	$100.57 - $116.37 $7.03 Million - $8.13 Million	-69,900 Reduced 5.08%	1,305,560 $146 Million
Q2 2024 Jul 26, 2024	SELL	$103.94 - $118.98 $5.95 Million - $6.81 Million	-57,200 Reduced 3.99%	1,375,460 $147 Million
Q1 2024 Apr 24, 2024	BUY	$115.19 - $132.77 $19 Million - $21.9 Million	165,200 Added 13.03%	1,432,660 $173 Million
Q4 2023 Feb 07, 2024	BUY	$114.26 - $136.0 $3.1 Million - $3.69 Million	27,100 Added 2.18%	1,267,460 $156 Million
Q3 2023 Oct 30, 2023	SELL	$122.0 - $145.31 $6.87 Million - $8.18 Million	-56,300 Reduced 4.34%	1,240,360 $161 Million
Q2 2023 Jul 31, 2023	SELL	$122.5 - $147.16 $1.37 Million - $1.65 Million	-11,200 Reduced 0.86%	1,296,660 $161 Million
Q1 2023 Apr 28, 2023	BUY	$133.98 - $160.47 $7.3 Million - $8.75 Million	54,500 Added 4.35%	1,307,860 $191 Million
Q4 2022 Feb 09, 2023	SELL	$129.72 - $159.85 $28.2 Million - $34.7 Million	-217,100 Reduced 14.76%	1,253,360 $200 Million
Q3 2022 Nov 10, 2022	SELL	$126.59 - $161.18 $987,402 - $1.26 Million	-7,800 Reduced 0.53%	1,470,460 $196 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $136 Million - $162 Million	960,860 Added 185.71%	1,478,260 $231 Million
Q2 2022 Aug 10, 2022	SELL	$141.59 - $168.66 $140 Million - $166 Million	-986,560 Reduced 65.6%	517,400 $45.1 Million
Q1 2022 May 11, 2022	SELL	$129.64 - $160.7 $1.1 Million - $1.37 Million	-8,500 Reduced 0.56%	1,503,960 $234 Million
Q4 2021 Feb 01, 2022	SELL	$119.87 - $145.67 $54 Million - $65.6 Million	-450,303 Reduced 22.94%	1,512,460 $193 Million
Q3 2021 Nov 09, 2021	BUY	$128.64 - $184.79 $86.2 Million - $124 Million	670,003 Added 51.83%	1,962,763 $256 Million
Q2 2021 Aug 10, 2021	BUY	$160.2 - $186.42 $207 Million - $241 Million	1,292,760 New	1,292,760 $230 Million

Others Institutions Holding JAZZ

# of Institutions

557

Shares Held

62.7M

Call Options Held

559K

Put Options Held

74.5K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.1B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Capital Management, LLC with notifications on news.

Account

Polaris Capital Management, LLC Jazz Pharmaceuticals PLC Transaction History